A Double-Blind, Randomized, Parallel Design Study To Assess the Safety and Pharmacokinetics of Terbinafine Hydrogen Cloride (HCl) Nail Lacquer Applied for 28 Days in Patients With Onychomycosis

Trial Profile

A Double-Blind, Randomized, Parallel Design Study To Assess the Safety and Pharmacokinetics of Terbinafine Hydrogen Cloride (HCl) Nail Lacquer Applied for 28 Days in Patients With Onychomycosis

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Oct 2014

At a glance

  • Drugs Terbinafine (Primary) ; Terbinafine (Primary) ; Terbinafine (Primary)
  • Indications Onychomycosis; Tinea pedis
  • Focus Adverse reactions
  • Sponsors Apricus Biosciences
  • Most Recent Events

    • 27 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top